The pharmacology of arachidonic acid-induced rat paw edema
- 1 August 1987
- journal article
- Published by Springer Nature in Inflammation Research
- Vol. 21 (3-4) , 303-305
- https://doi.org/10.1007/bf01966498
Abstract
Arachidonic acid (AA) injected into hindpaws of Lewis rats produces a severe edematous response. Treatment with corticosteroids (dexamethasone, prednisolone), dual inhibitors of arachidonate metabolism (phenidone, SK & F 86002), anti-histamine/serotonin agents (chlorpheniramine, cyproheptadine) and a gold compound (auranofin) inhibited AA-induced edema. In contrast, administration of high doses of cyclooxygenase inhibitors (indomethacin, piroxicam, naproxen, ibuprofen, meclofenamic acid and tiflamizole) did not affect AA-induced hind paw edema. The involvement of lipoxygenase products and mast cell mediators in the edematous response to arachidonic acid render this model potentially useful for studying antiinflammatory agents with a mechanism of action different from that of cyclooxygenase inhibitors.Keywords
This publication has 7 references indexed in Scilit:
- SK&F 86002: A structurally novel anti-inflammatory agent that inhibits lipoxygenase- and cyclooxygenase-mediated metabolism of arachidonic acidBiochemical Pharmacology, 1987
- Modulation of mouse ear edema by cyclooxygenase and lipoxygenase inhibitors and other pharmacologic agentsInflammation Research, 1985
- The Mouse Ear Inflammatory Response to Topical Arachidonic AcidJournal of Investigative Dermatology, 1984
- Leukotriene B4, a mediator of inflammation present in synovial fluid in rheumatoid arthritis.Annals of the Rheumatic Diseases, 1983
- Lipid mediators of inflammation and allergy.1982
- 1-phenyl-3-pyrazolidone: An inhibitor of cyclo-oxygenase and lipoxygenase pathways in lung and plateletsProstaglandins, 1978
- ANTIARTHRITIC PROPERTIES AND UNIQUE PHARMACOLOGIC PROFILE OF A POTENTIAL CHRYSOTHERAPEUTIC AGENT - SK AND F D-391621976